Alternate-day S-1 Oral Therapy for Frail Patients With Metastatic Colorectal and Pancreatic Cancer
Alternate-day S-1 therapy appears to be a feasible and effective treatment option for frail patients with metastatic colorectal and pancreatic cancer. Continuous monitoring of the NLR and VES-13 scores can aid in the stratification of patients, ensuring that treatment intensity is appropriately matched to the patient's condition.
Authors
- Junkichi Kanda
- Masataka Sasaki
- Naoki Odaira
- Katsuki Muneoka
Institutions
- Nagara Medical Center (JP)
Publication Details
- Journal
- In Vivo
- Published
- 2025-06-27
- DOI
- https://doi.org/10.21873/invivo.14044
- Primary Topic
- Colorectal Cancer Treatments and Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00